OncUView.tv - Video Library - Oncology News and Information for Healthcare Professionals > High Expression of CRBN That Is Associated With Improved Clinical Responses in Multiple Myeloma Patients — interview with Daniel Heintel, MD, at ASH 2

Install latest flash player if this video gallery doesn't work.

High Expression of CRBN That Is Associated With Improved Clinical Responses in Multiple Myeloma Patients — interview with Daniel Heintel, MD, at ASH 2
At the American Society of Hematology (ASH) 2011, Daniel Heintel, MD, Wilhelminenspital, Vienna, Austria, discusses the high expression of Cereblon (CRBN) that is associated with improved clinical responses in multiple myeloma patients treated with lenalidomide and dexamethasone. Accompanying this interview is a downloadable copy of the abstract.